Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Efficiency of pharmacogenetic approach to anticoagulant therapy in patients with prosthetic heart valves].

Kardiologiia - 6 Aug 2019

Gorbunova E V, Rozhnev V V, Ponasenko A V, Barbarash Olga Leonidovna

Abstract excerpt

BACKGROUND: This study examined clinical, demographic, anthropometric, and inheritance factors that influence individual sensitivity to warfarin therapy after heart valve surgery. The clinical significance of the pharmacogenetic approach was assessed using the individual time frame and time spent in the INR therapeutic range. AIMS: We determined the clinical outcome of the pharmacogenetic approach at the start of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticoagulants
Share to Cytochrome P-450 CYP2C9
Share to Heart Valves

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to International Normalized Ratio

Share to Pharmacogenomic Testing

Share to Siberia

Share to Vitamin K Epoxide Reductases

Share to Warfarin

Source

Identifiers

PMID: 31644414
DOI: 10.18087/cardio.n681

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Efficiency of pharmacogenetic approach to anticoagulant therapy in patients with prosthetic heart valves].PMID 31644414Read ↗

Genetic influence on bleeding and over-anticoagulation risk in patients undergoing warfarin treatment after heart valve replacements.Semantic proximity Read ↗

Genotype-Guided Warfarin Dosing in Patients With Mechanical Valves: A Randomized Controlled Trial.Semantic proximity Read ↗

Pharmacogenetic variants influence vitamin K anticoagulant dosing in patients with mechanical prosthetic heart valves.Semantic proximity Read ↗

Factors influencing quality of anticoagulation control and warfarin dosage in patients after aortic valve replacement within the 3 months of follow up.Semantic proximity Read ↗

A clinical study of genetic testing to guide the dosing of warfarin after heart valve replacement.Semantic proximity Read ↗

Integrated analysis of clinical and genetic factors on the interindividual variation of warfarin anticoagulation efficacy in clinical practice.Semantic proximity Read ↗

Association between gene polymorphisms and initial warfarin therapy in patients after heart valve surgery.Semantic proximity Read ↗

Pharmacist-Led Genotype-Guided Warfarin Therapy in Valve Replacement: An Observation Cohort Study.Semantic proximity Read ↗

Genotype-guided warfarin dosing may benefit patients with mechanical aortic valve replacements: randomized controlled study.Semantic proximity Read ↗

Mechanical heart valve recipients: anticoagulation in patients with genetic variations of phenprocoumon metabolism.Semantic proximity Read ↗

Influence of VKORC1 and CYP2C9 Polymorphisms on Daily Acenocoumarol Dose Requirement in South Indian Patients With Mechanical Heart Valves.Semantic proximity Read ↗

The influence of genetic polymorphisms and interacting drugs on initial response to warfarin in Chinese patients with heart valve replacement.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.